Intrinsic Value of S&P & Nasdaq Contact Us

Teleflex Incorporated TFX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
$142.15
+13.5%
Analyst Price Target
$133.25
+6.4%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Teleflex Incorporated (TFX) has a negative trailing P/E of -5.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 18.8 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -17.04%, forward earnings yield 5.33%. PEG 1.39.

Criteria proven by this page:

  • VALUE (78/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Forward P/E 18.8 — analysts expect a return to profitability with estimated EPS of $6.67 for FY2026.
  • PEG Ratio 1.39 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield -17.04% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 5.33% as earnings recover.
  • Analyst consensus target $133.25 (+6.4% upside) — modest upside expected.

Overall SharesGrow Score: 48/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
48/100
SG Score
View full scorecard →
VALUE
78/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
40/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — TFX

Valuation Multiples
P/E (TTM)-5.9
Forward P/E18.8
PEG Ratio1.39
Forward PEG1.39
P/B Ratio1.70
P/S Ratio1.79
EV/EBITDA69.4
Per Share Data
EPS (TTM)$-20.47
Forward EPS (Est.)$6.67
Book Value / Share$70.64
Revenue / Share$66.99
FCF / Share$5.55
Yields & Fair Value
Earnings Yield-17.04%
Forward Earnings Yield5.33%
Dividend Yield1.13%
SharesGrow IV$142.15 (+13.5%)
Analyst Target$133.25 (+6.4%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 29.4 -4.23 3.26 3.74 0.84%
2017 73.4 -1.92 4.61 5.22 0.55%
2018 58.8 1.99 4.65 4.82 0.53%
2019 37.7 0.30 5.84 6.70 0.36%
2020 57.1 -2.05 5.73 7.54 0.33%
2021 31.7 0.72 4.09 5.47 0.41%
2022 32.2 -1.27 2.91 4.19 0.54%
2023 32.9 -15.90 2.64 3.94 0.55%
2024 119.6 -1.49 1.95 2.74 0.76%
2025 -6.0 0.00 1.74 2.73 1.11%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $4.98 $1.87B $237.38M 12.7%
2017 $3.27 $2.15B $152.53M 7.1%
2018 $4.29 $2.45B $200.8M 8.2%
2019 $9.80 $2.6B $461.47M 17.8%
2020 $7.09 $2.54B $335.32M 13.2%
2021 $10.23 $2.81B $485.37M 17.3%
2022 $7.68 $2.79B $363.14M 13%
2023 $7.53 $2.97B $356.33M 12%
2024 $1.48 $3.05B $69.68M 2.3%
2025 $-20.25 $1.99B $-905.64M -45.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $6.67 $6.32 – $8.16 $2.29B $2.28B – $2.3B 7
2027 $10.14 $8.19 – $12.50 $2.4B $2.39B – $2.43B 6
2028 $11.58 $11.51 – $11.70 $2.53B $2.51B – $2.55B 1
2029 $10.04 $9.98 – $10.15 $2.69B $2.68B – $2.71B 1
2030 $11.07 $11.00 – $11.19 $2.84B $2.82B – $2.86B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message